<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Publications | The Miller Lab</title>
    <link>/publication/</link>
      <atom:link href="/publication/index.xml" rel="self" type="application/rss+xml" />
    <description>Publications</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Tue, 01 Jan 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/img/MLab_logo_5.png</url>
      <title>Publications</title>
      <link>/publication/</link>
    </image>
    
    <item>
      <title>Clinical spectrum of cutaneous melanoma morphology.</title>
      <link>/publication/clinical-spectrum-of-melanoma/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/clinical-spectrum-of-melanoma/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/30165162&#34; target=&#34;_blank&#34;&gt;Clinical spectrum of cutaneous melanoma morphology.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Eczema Tvecium</title>
      <link>/publication/eczema-tvecium/</link>
      <pubDate>Thu, 01 Nov 2018 00:00:00 +0000</pubDate>
      <guid>/publication/eczema-tvecium/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/30454071&#34; target=&#34;_blank&#34;&gt;Kaposi&amp;rsquo;s varicelliform eruption in a patient with metastatic melanoma and primary cutaneous anaplastic large cell lymphoma treated with talimogene laherparepvec and nivolumab.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Role of CDK7 in Melanoma</title>
      <link>/publication/cdk7/</link>
      <pubDate>Sun, 01 Jul 2018 00:00:00 +0000</pubDate>
      <guid>/publication/cdk7/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/29408204&#34; target=&#34;_blank&#34;&gt;High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>A Complete Response in cSCC with Ipi/Nivo</title>
      <link>/publication/cr-ipi-nivo-scc/</link>
      <pubDate>Fri, 08 Sep 2017 00:00:00 +0000</pubDate>
      <guid>/publication/cr-ipi-nivo-scc/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/28932782&#34; target=&#34;_blank&#34;&gt;Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Somatic Driver Mutations in Melanoma</title>
      <link>/publication/somatic-drivers-melanoma/</link>
      <pubDate>Fri, 19 May 2017 00:00:00 +0000</pubDate>
      <guid>/publication/somatic-drivers-melanoma/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.30593&#34; target=&#34;_blank&#34;&gt;Somatic driver mutations in melanoma.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>A novel multi-CDK inhibitor in Melanoma</title>
      <link>/publication/multi-cdk-inhibitor-in-melanoma/</link>
      <pubDate>Sat, 02 Jul 2016 00:00:00 +0000</pubDate>
      <guid>/publication/multi-cdk-inhibitor-in-melanoma/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/26810603&#34; target=&#34;_blank&#34;&gt;A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Molecularly Targeted Therapies and Immunotherapies For Melanoma</title>
      <link>/publication/review-of-molecularly-targeted-therapies-and-immunotherapies-for-melanoma/</link>
      <pubDate>Wed, 01 Jun 2016 00:00:00 +0000</pubDate>
      <guid>/publication/review-of-molecularly-targeted-therapies-and-immunotherapies-for-melanoma/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/25085663&#34; target=&#34;_blank&#34;&gt;Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>CDKs as Therapeutic Targets in Melanoma</title>
      <link>/publication/cdk-inhibotrs-in-melanoma/</link>
      <pubDate>Tue, 17 May 2016 00:00:00 +0000</pubDate>
      <guid>/publication/cdk-inhibotrs-in-melanoma/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/24405945&#34; target=&#34;_blank&#34;&gt;Cyclin-dependent kinases as therapeutic targets in melanoma.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Molecular testing in melanoma</title>
      <link>/publication/molecular-testing-in-melanoma/</link>
      <pubDate>Sun, 01 May 2016 00:00:00 +0000</pubDate>
      <guid>/publication/molecular-testing-in-melanoma/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pubmed/24534656&#34; target=&#34;_blank&#34;&gt;Commentary: Molecular Testing in Melanoma.&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
